Tormere Analytics
OverviewStock ResearchPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Pricing
Privacy PolicyTerms of Service

PBLS

$36.32-6.30%website ↗

Parabilis Medicines, Inc.

Market Cap
$61.3B
Sector
Materials
Industry
Biotechnology
Beta
—
Insufficient price history
Price Chart
Loading…

Signals

Insider Velocity
26.4x
buying
Congress
—
recent trades
Short Volume
74%
W/W -9.0pp

Market & Alt Data

News
11
recent articles
Activist
13D
RA
Analyst Consensus
Strong Buy
11 analysts
Velocity Score
26.39x
Current Rate (90d)
244037.14/mo
Baseline Rate
0.00/mo
Unique Buyers (90d)
4
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-07-222026-07-22RA CAPITAL MANAGEMENT, L.P.DirectorPurchase47.3K$29.77$1.41M26.53MView
2026-07-212026-07-22RA CAPITAL MANAGEMENT, L.P.DirectorPurchase65.9K$29.25$1.93M26.48MView
2026-07-202026-07-22RA CAPITAL MANAGEMENT, L.P.DirectorPurchase131.4K$27.28$3.58M26.42MView
2026-06-112026-06-29Levy Guy10% OwnerPurchase500.0K$20.00$10.00M1.03MView
2026-06-152026-06-16SEBULSKY ALANDirectorPurchase9,065$26.49$240K30.0KView
1–5 of 8
1 / 2

Recent News

Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Yahoo · 2026-09-01
Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors
Yahoo · 2026-08-25
Young startups miss out on biotech venture funding rebound, MassBio says
Yahoo · 2026-08-25
Parabilis Medicines: A Rare-Tumor Validation Ladder For An Undruggable Platform
SeekingAlpha · 2026-08-14

Informational purposes only, not investment advice.

Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
Yahoo · 2026-08-13
Parabilis Medicines Q2 EPS $(2.32) Misses $(0.08) Estimate, Sales $148.000K Miss $25.000M Estimate
Benzinga · 2026-08-13
Fresh Off IPO, A Director Buys $474,000 of Parabilis Medicines Stock. Is PBLS a Buy?
Yahoo Finance · 2026-06-20
Parabilis Medicines (PBLS) Stock Valuation After Recent 10% Single Day Decline
Yahoo Finance · 2026-06-15
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Yahoo Finance · 2026-06-11
How to Play PBLS Stock After the Parabilis IPO
Yahoo Finance · 2026-06-11
Parabilis Medicines Announces Pricing of Upsized Initial Public Offering
Yahoo Finance · 2026-06-10

Factor Profile

Pro
Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →
Pipeline
Phase 1
1 active trial · readout 2027-04